EWL vs. THNR ETF Comparison
Comparison of iShares MSCI Switzerland Capped Index Fund (EWL) to Amplify Weight Loss Drug & Treatment ETF (THNR)
EWL
iShares MSCI Switzerland Capped Index Fund
EWL Description
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Switzerland 25/50 Index. The fund will at all times invest at least 80% of its assets in the securities of its underlying index and in depositary receipts ("DRs") representing securities in its underlying index. The MSCI Switzerland 25/50 Index consists of stocks traded primarily on the Zurich Stock Exchange. A capping methodology is applied that limits the weight of any single component to a maximum of 25% of the MSCI Switzerland 25/50 Index. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$51.02
Average Daily Volume
326,453
2
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.Grade (RS Rating)
Last Trade
$26.93
Average Daily Volume
3,732
6
Performance
| Period | EWL | THNR |
|---|---|---|
| 30 Days | 3.61% | 7.12% |
| 60 Days | 5.13% | 2.76% |
| 90 Days | 3.73% | 4.16% |
| 12 Months | 15.17% |
0 Overlapping Holdings
| Symbol | Grade | Weight in EWL | Weight in THNR | Overlap |
|---|
EWL: Top Represented Industries & Keywords
THNR: Top Represented Industries & Keywords
Compare ETFs
